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Zaigham Abbas, Wasim Jafri ( Department of Medicine, The Aga Khan University Hospital, Stadium Road, Karachi. )

Yoghurt is one of the staple dairy products of Indo-Pakistan subcontinent. This is the name given to the
traditional yoghurt which is prepared and sold commercially in the earthenware pans. The simmering
milk is cooled down in these pans and is inoculated with the starter substance from the previous day’s
dahi. Lassi, prepared from dahi is a popular beverage. Yoghurt is taken with meals as bland or with
added salt or sugar and with salads. It is also recommended as a source of nutrition and household
remedy for ill health, pOor appetite and digestive disturbances. Dahi oryoghurt is produced by the
fermentation of milk. The bacteria involved are the lactobacillus bulgaricus and streptococcus
thermophilous. In a study by Naeem and Rizvi1, organisms cultured from dahi were streptococcus
lactic, streptococcus thermophilous, lactobacillus acidophilus, lactobacillus casei, lactobacillus
bulgaricus and leuconostoc citrovorum. The pH varied between 3.4 to 6.0. Many claims have been
made concerning prophylactic and therapeutic effects of yoghurt. Yoghurt is rich in nutrients and
probiotics. Probiotics are live microbial feed supplements which beneficially affect the host animal by
improving microbial balance2. Our intestinal microflora provide protection against various diseases.
Yoghurt starter bacteria, lactobacillus bulgaricus and streptococcus thermophilous are the part of
probiotic preparations currently on the market. They may be operating by production of antimicrobial
substances, competition for adhesion to receptors and stimulation of immunity3. Although there are
many claims of yoghurt and its probiotic effects, the amelioration of symptoms of lactose intolerance
has been worked in details.
Lactose intolerance
Kolars et al4 showed that lactose was better absorbed in lactase deficient subjects after ingestion of
yoghurt than after consumption of milk or powdered lactose in water despite nearly equal lactose loads.
Ingestion of 18 grams of lactose in yoghurt resulted only about one third as much hydrogen excretion
in breath as a similar load of lactose in milk or water. This enhanced absorption is believed to be due to
B galactosidase (B gal) activity of its endogenous bacteria. Lactobacillus bulgaricus and streptococcus
thermophilous produce higher amount of lactase or B gal than other microorganisms with lactase
potentials 5,6 . 40-50% of the lactose is hydrolyzed during fermentation5, the residual level of lactose
and high lactase activity make yoghurt very suitable product for lactase deficient persons who can
absorb roughly 50% of a lactose load; a finding supported by direct measurement of lactose absorption
through aspiration of the terminal ileum7. The buffering capacity of yoghurt protects the bacteria and
their enzymes from gastric degradation by slowing the decrease of gastric pH8. It has been shown that
three times more acid is required to acidify yoghurt than to acidify milk8. Yoghurt B gal was stable at
pH 4.0 but inactivated at lower pH. However, this buffering capacity also prevents microbial B gal
from hydrolysing lactose in the duodenum9. Moreover, as pH is still low in duodenum, so B gal is not
active and process of hydrolysis and absorption occurs lower down in the small intestine where the pH
is progressively increased. Intracellular location of the enzyme and integrity of the bacterial cell
membrane is an additional protective factor from acidic pH8. When yoghurt was sonicated to disrupt
microbial cell structure, only 20% of the activity remained after incubation at pFI 4.0 for 60 minutes.
Acidified milk alone or with disrupted yoghurt microorganisms caused twice as much lactose
malabsorption as did the acidified milk containing intact organisms8. Some experimental studies
suggest that yoghurt may increase the lactase activity in mucosal cells either by adherence of lactase of

bacterial origin10 or by stimulation of brush border of the enterocytes11. A recent study did not
demonstrate any increase in the lactase or B gal activity in the intestinal mucosa after a long term (8
day) ingestion of yoghurt12. Biopsies in this study were taken from the 3rd part of duodenum, 10-12
hours after the last yoghurt ingestion, so this study does not show what happens to the enzyme activity
lower down in intestine. The results are contrary to a previous experimental study in rats which showed
increase in enzyme activity after prolonged yoghurt intake13. The orofaecal transit time for yoghurt is
significantly longer than the milk. This allows greater time for any residual intestinal lactase activity to
act. This also explains the better absorption even from heated yoghurt as compared to milk in some
studies14, while other workers have shown that the beneficial effect of yoghurt is destroyed by
pasteurization12. It has been shown that microbial endogenous lactase is superior to exogenous
commercial lactase in alleviating lactose maldigestion15. Though the commercially available
preparations do their job16, they are expensive. Moreover, to get the best results one has to incubate the
milk with them before consumption to achieve lactose hydrolysis 17. All yoghurts are not created equal.
Lactose malabsorbing subject may absorb lactose better from different brands of yoghurt. This
variation could be due to whether products were pasteurized which had destroyed the B gal activity,
way of storage and transport and intrinsic differences in the B gal activity of cultures18. This would not
be a great problem in case of yoghurt which is produced by the shopkeepers on daily basis and no heat
treatment is given to the formed product. Lactose malabsorption frequently occurs in patients with
symptomatic giardiasis 19 because of the non-specific damage to the mucosa of the infection site by
various mechanisms20-22. Such children may benefit from the administration of yoghurt whose lactose
appears to be well absorbed23. Yogliurt may be an appropriate food for the renutrition of malnourished
children with chronic diarrhoea and lactase deficiency24.
Cancer
Antitumour activity of yoghurt has been studied in experimental animals. Feeding of fermented milk
products decreased the DNA synthesis of intraperitoneally transplanted ehrlich ascitic tumours25.
Lactobacilli used in the fermentation of milk products, may survive in the digestive tract26 and interfere
with other gut bacteria. Alternation in the intestinal bacterial enzyme activity was observed during
feeding milk supplements with lactobacillus acidophilus27,28. Oral administration of such strains
decreased the concentration of three faecal enzymes (B glucuronidase, azoreductase, nitroreductase) 28
that had the capacity to convert procarcinogens to carcinogens in the colon. Another study confirmed
decrease in nitroreductase activity but B glucuronidase and azoreductase activity remained unchanged29. Difference in the strains of lactobacilli are likely to be responsible for these differences but
this study confirmed that the lactobacillus acidophilus and bilIdobacterium bifidum in the daily
products lead to metabolic changes in the colonic flora. Such changes may influence estrogen, steroid
and bile acid metabolism and interfere enterohepatic circulation30-33. Moreover, glycopeptides from the
cell wall of lactobacillus bulgaricus have shown to have antitumour action34. Furthermore, microorganisms provided by yoghurt may stimulate immunological activity in the host and increase
interferon production by the lymphocytes35. Lactobacillus casei given per os to the mice has shown to
increase the phagocytic activity of macrophages36. The immune stimulation could be relevant to the
dietary yoghurt’s effect on inhibition of tumour cell proliferation. In a case control study from
Netherlands a significantly lower consumption of fermented milk products was observed among breast
cancer cases as compared to the population controls37.
Intestinal infections
Oral antibiotics often alter the intestinal flora and this may end up in pseudo-membranous colitis38.
This disease caused by clostridium difficile can be cured by administration of faecal enema from

healthy adults39. A particular strains of lactobacillus is effective in preventing relapses of pseudo
membranous colitis40. Bifidobacterium longum is a part of normal intestinal microflora. Yoghurt
containing this species may decrease the frequency of gastrointestinal disorders by reducing antibiotic
induced alternations in the intestinal microflora41. In addition to the restoration of intestinal microflora,
yoghurt also has some antimicrobial effect. Antibiotic production have been shown by lactic
streptococci and lactic bacilli42. Low pH due to lactic acid has also shown to kill pathogens but acidity
may not always be enough to be bacteriocidal. Various pathogens may survive in yoghurt or dahi.
Contamination may occur during handling of milk, inoculation and storage. Staphylococcus aureus,
streptococcus faecalis, escherichia coli, enterobacter aerogenosa, bacillus cereus, yeasts and mould
have been recovered from some of the specimens of dahi from Lahore1. It is important to observe all
hygienic measures while dealing with dahi. Fermented milk consumption decreases the incidence of
salmonella carrier state43 and reduces the risk of travellers diarrhoea caused by enterotoxigenic
escherichia coli44. Volatile fatty acids produced by lactic acid bacteria may be responsible for
controlling the colonization of the gut by shigella sonnei and E. coli45.
Osteoporosis
Calcium supplementation in the form of dairy products decreases the rate of vertebral bone loss in
premenopausal women46. In another study women with postmenopausal idiopathic osteoporosis were
found to have significantly greater chance of lactase deficiency47 which could predispose to
osteoporosis either through reduced intake of milk secondary to intolerance or impaired calcium
absorption. Though the presence of lactose enhances absorption of calcium from the milk; in lactase
deficiency it might inhibit its absorption48-50. The yoghurt would certainly be a better choice in terms
of tolerance to overcome the problem of decrease dietary intake of calcium. The relation of lactase,
lactose and calcium appears to be a complex one as one of the studies showed that calcium was
absorbed equally well from milk and yoghurt in hypolactasic subjects51. Further work is needed to
resolve the issue.
Miscellaneous
Yoghurt, like milk is a good source of protein, riboflavin, folic acid and calcium. Its folic acid content
is higher than the milk52. Digestibility of the milk protein is increased due to its partial predigestion
during the fermentation process53. Yoghurt may be used by the geriatric population as a mild laxative54
because of its lactose and lactic acid content. It also has hypocholesterolemic effect 55 but such activity
is also present in the milk. It is hoped that in the years to come much more detailed and important
scientific knowledge would be available for this ancient natural food.
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